Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Poster De Conférence Année : 2018

Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity

Résumé

Autoimmune diseases can develop following pathological activation of autoreactive effector cells and/or, alternatively, after weakening of self-protective regulatory mechanisms. Most of the studies have focused on CD4+ Tregs and the role of CD8+ Tregs in Multiple Sclerosis (MS) remains largely unexplored. We previously reported the suppressive properties of rat and human CD8+CD45RCint/neg Treg cells, expressing Foxp3 and acting through IFNg, TGFb and IL34 cytokines (Guillonneau, JCI, 2007; Bézie, JCI, 2015, Bézie, Front. Immunol., 2018). Thus, their potency of suppression make them strong candidates of disruptive immune tolerance, especially in MS where CD8+ T cells play a major role. Thus, the overreaching goal of this study is to define the role of CD8+ regulatory T cell in MS pathogenesis.
Fichier principal
Vignette du fichier
Poster ECTRIMS Naïl Benallegue pour impression (1).pdf (684.63 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-02159755 , version 1 (19-06-2019)

Identifiants

  • HAL Id : inserm-02159755 , version 1

Citer

Naïl Benallegue, Bryan Nicol, Séverine Bézie, Hadrien Regue, Nadège Vimont, et al.. Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity. ECTRIMS 2018 (34th congress of the european committee for treatment and research in Multiple Sclerosis), Oct 2018, Berlin, Germany. ⟨inserm-02159755⟩
85 Consultations
89 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More